A new group of recessively inherited metabolic disorders affecting glycoprotein metabolism has been identified-the carbohydrate-deficient-glycoprotein
(CDG) syndromes. Here the course and clinical expression of CDG syndrome type I in 13 patients who have passed the age of 15 years are described. All presented with early onset psychomotor retardation, in most cases combined with slight facial dysmorphic features, some degree of hepatic dysfunction, and in one case, pericardial effusion. About half of the patients had subcutaneous lipodystrophy and comatose or stroke-like episodes during childhood. After the age of 15 the disease was mainly characterised by neurological symptoms consisting of non-progressive ataxia associated with cerebellar hypoplasia, stable mental retardation, variable peripheral neuropathy, and strabismus. One third of the patients had generalised seizures, usually sporadic, and all had retinal pigmentary degeneration. In all cases there was more or less pronounced thoracic deformity and no female had passed puberty. Also, the oldest female showed premature aging. Severe internal organ symptoms, which are common in pediatric patients, were absent. All patients had highly raised serum concentrations of the biochemical marker carbohydrate-deficient transferrin, which can be used to verify the diagnosis. It is concluded that after childhood, CDG syndrome type I is a largely non-progressive disease compatible with a socially functioning but dependent lifestyle. C( Neurol Neurosurg Psychiatry 1994;57: [552] [553] [554] [555] [556] In recent years a new group of inborn errors of glycoprotein metabolism has been recognised.' Due to unique carbohydrate defects in secretory glycoproteins they have been termed carbohydrate-deficient glycoprotein (CDG) syndromes, of which three clinical and biochemical types have now been identified. The first described and best known, type I, seems to affect early neuronal development, whereas types II and III may be associated with dysmyelination or hypomyelination. All three types have variable manifestations outside the nervous system.1-3
The paediatric symptomatology in CDG syndrome type I is now well documented. In summary, in infancy and childhood the disease is primarily manifested by neurological symptoms consisting of psychomotor retardation, cerebellar and oculomotor dysfunction, peripheral neuropathy, comatose and strokelike episodes, epilepsy, and retinal pigmentary degeneration. Other early manifestations are common including nutritional problems, hepatic dysfunction, pericardial effusions, infections, coagulation defects, nephropathy, osteopenia with skeletal deformities, and dystrophic alterations of adipose tissue and skin. [1] [2] [3] [4] [5] [6] [7] [8] [9] The biochemical changes are dominated by a unique carbohydrate deficiency in a number of serum glycoproteins, which is most readily seen in transferrin.F'8'3 Some of this glycoprotein lacks two or all of its four terminal trisaccharides,'012 and this aberration can be used as a diagnostic biochemical marker of CDG syndrome type J.12 The ultrastructural changes described in liver and sural nerve biopsies are also characteristic, and particularly consist of various kinds of intracellular inclusion bodies and of attenuated myelin sheaths.5I 16 In a few necropsy examinations on children, olivopontocerebellar atrophy has been found, with nerve cell depletion and gliosis.8 17 The clinical expression of CDG syndrome type I in adult patients is incompletely known. We therefore describe here the course and manifestations of CDG syndrome type I in 13 patients who are now past the age of 15 In 11 cases serum levels of aspartate-and alanine amino-transferase (ASAT, ALAT) and y-glutamyl transferase (GT) were determined after the age of 15 years, as were concentrations of total transferrin (TT), thyroxine binding globulin (TBG), a,-antitrypsin (AT), and apolipoprotein B (single radial immunodiffusion). Determination of carbohydrate-deficient transferrin (CDT) by anion exchange chromatography,'2 and immune isoelectric focusing of transferrin"2 were carried out in all patients after that age.
Results

CLINICAL SYMPTOMS
In all cases symptoms had been present during the first year of life. Presenting symptoms were failure to thrive or developmental delay in 12 instances, and in one patient a pericardial exudate. At first examination a slightly dysmorphic appearance6 18 was seen in at least 10 patients, subcutaneous lipodystrophy45 18 was specifically mentioned in six cases, and all had convergent strabismus (table 1). In eight patients there had been feeding difficulties, and hepatopathy of varying degree was present in those eight cases who had been examined for liver function. One patient had developed a Reye-like syndrome in connection with varicella. From the second half of the first year, psychomotor retardation was evident with a combined cerebellar ataxia and peripheral neuropathy. None were able to walk, even with support, before the third year (table 2) . During early childhood, generalised seizures had occurred in eight patients, and five had comatose or stroke-like episodes usually in connection with infections or trauma (table  1) . The stroke-like episodes consisted of sudden focal cerebral symptoms lasting from a few hours up to three months. Within the first few years retinal pigmentary degeneration was found in all patients, as well as some thoracic deformity-for example, pigeon chest, scoliosis, or kyphosis (table 1) .
During childhood and adolescence the neurological symptoms remained stable except for a slow gradual deterioration of the peripheral neuropathy, at least in those patients who had been followed up regularly. After the age of 14 years, stroke-like episodes had ceased to appear. Liver enzyme activities improved and feeding difficulties and lipodystrophy disappeared. Two patients had had signs of increased bleeding tendency, and one had a subclinical, verified deficiency of factors IX and XI.
At the age when this examination was carried out, moderate to severe but stable cerebellar ataxia and dyscoordination were present in all cases. Speech was primitive and "telegrammatic", with pronounced dysarthria, and three patients showed facial, truncal, and hand hyperkinesias when excited (table 1). All patients had some, but variable, muscular atrophy and weakness of the distal lower limbs (figs lA, C, and D). Weak tendon reflexes could be elicited in five patients but were absent in eight. Only three male patients (aged 34-44 years) with mild neuropathy were able to walk atactically without support. Sporadic seizures continued to occur in four cases. All 13 patients had permanent, alternating, convergent strabismus (figs 1B, 2A, and 2B) and retinal pigmentary degeneration, but none were blind. Mental retardation was severe to moderate but non-progressive and combined with a most social, extrovert, and affectionate behaviour (table 1). Two patients had a remarkable memory for music. Five patients were able to read simple texts and to write short sentences (table 2) . Understanding was generally better than expressive intellectual and motor capability. All patients had graduated from or were still attending special school, and seven of them had sheltered employment.
The seven males had apparently passed puberty and developed secondary sexual characteristics, whereas no female had shown any signs of puberty (table 1) . The oldest female, now 50 years old, showed signs of premature aging (fig 2A) . Eleven patients were short; two brothers were within normal height but were shorter than their healthy brother (table 1, fig 1) . In six cases the thoracic and spinal deformity had become pro- fig ID) . The facial features were characteristic with prominent jaws, large ears, and a broad nose base ( fig 1A, 2A) distal neuropathy. In the oldest female patient, no responses were recorded from the peroneal nerves at the age of 47. The two patients who were examined repeatedly showed a gradual slowing of the peroneal nerve conduction velocities, at least until the age of 14.
BIOCHEMICAL ANALYSES
After the age of 15 years, ASAT or ALAT levels, or both, were slightly raised in three of 11 patients, ranging between 0-9 and 3-8 pcat/l.
Serum concentrations of TBG were reduced in six of 11 patients (mean 8-85 (SD 2-37)) mg/I, reference range 10-40 mg/l), and apolipoprotein B was reduced in five of 11 cases (mean 0 50 (0-27) g/l, reference range 0-48-1'58 g/l). The serum concentration of AT was below normal in nine of 11 patients (mean 1 98 (1-25) g/l, reference range 2-0-3-28 g/l). Concentration of TT was normal in all but one patient (mean 2-82 (0-84) g/l, reference range 2-02-3-99 g/l).
Determination of CDT in serum showed greatly increased values in all instances with a mean of 146 (36) mg/l (reference level in men < 17 mg/l and in women < 22 mg/l) (table 3) . There were no significant correlations between the values of any of the analysed proteins except between TBG and apolipoprotein B (r = 0-613, p < 0-025). Only apolipoprotein B was correlated with age (r = 0-836, p < 0-0005).
Immune isoelectric focusing of serum transferrin showed pronounced concentrations of abnormal isotransferrins corresponding to isoforms with two and four deficient carbohydrate chains, which is typical for CDG syndrome type .4-6 11 12 Discussion These 13 patients, with a median age of 23 years, represent the oldest group with CDG syndrome known to us. Altogether, we have diagnosed 60 cases with type I as of April 1993, and data from another eight patients have been reported,' 9 13 14 representing 11 nationalities on three continents. The present patients show certain differences compared with many of the described paediatric cases. This report may therefore cast new light on the course and prognosis of CDG syndrome after the childhood stage with an estimated mortality of 15%-20%. '8 Except for transient pericardial exudate in one patient and a Reye-like syndrome in another, none of them had had life threatening complications during infancy and childhood, such as severe infections, haemorrhages, or systemic organ failure, which have been reported repeatedly in paediatric cases.5 6 8 9 17 18 The low frequency of those types of dramatic manifestations is probably responsible for the good prognosis for long term survival, and may have provided more favourable conditions for psychomotor development. It is possible that these patients represent a more benign phenotype than those with early severe multisystemic manifestations.
The course of the disease from adolescence was dominated by the neurological symptoms, which seemed to be stable with the possible exception of a slow deterioration of the peripheral neuropathy. The degree of neuropathy in the oldest patients was, however, variable, from very mild to severe. Walking ability seemed to be limited by the severity of the neuropathy. Cerebellar and mental symptoms remained stable and all patients achieved a socially functioning but dependent lifestyle. The frequency of epilepsy decreased, necessitating treatment in only one third of the patients, and stroke-like episodes disap-peared completely. A slow progression of retinal pigmentary degeneration has previously been noted in younger patients. ' 
